Syndax Pharmaceuticals (SNDX) EBIT Margin Growth (1y) (2016 - 2026)
Syndax Pharmaceuticals (SNDX) EBIT Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Syndax Pharmaceuticals |
1.69 Bn |
1.34 Bn |
53.02 Mn |
36,518.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
36,518.00 |
| Dec 31, 2025 |
116,374.00 |
| Sep 30, 2025 |
59,143.00 |
| Jun 30, 2025 |
193,775.00 |
| Dec 31, 2021 |
530,196.00 |
| Sep 30, 2021 |
507,638.00 |
| Jun 30, 2021 |
-151,029.00 |
| Mar 31, 2021 |
-318,285.00 |
| Dec 31, 2020 |
-148,816.00 |
| Sep 30, 2020 |
-176,887.00 |
| Jun 30, 2020 |
-32,612.00 |
| Mar 31, 2020 |
-7,625.00 |
| Dec 31, 2019 |
134,947.00 |
| Sep 30, 2019 |
123,799.00 |
| Jun 30, 2019 |
94,380.00 |
| Mar 31, 2019 |
130,343.00 |
| Dec 31, 2018 |
-345,402.00 |
| Sep 30, 2018 |
35,687.00 |
| Jun 30, 2018 |
-46,190.00 |
| Mar 31, 2018 |
-89,102.00 |
